Teva Pharmaceutical Industries Insider Sold Shares Worth $952,464, According to a Recent SEC Filing-June 2024-www.financetom.com

Teva Pharmaceutical Industries Insider Sold Shares Worth $952,464, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Teva Pharmaceutical Industries Insider Sold Shares Worth $952,464, According to a Recent SEC Filing

Jun 16, 2025 1:29 PM

04:09 PM EDT, 06/16/2025 (MT Newswires) -- Eliyahu Sharon Kalif, Executive Vice President, Chief Financial Officer, on June 12, 2025, sold 55,775 shares in Teva Pharmaceutical Industries ( TEVA ) for $952,464. Following the Form 4 filing with the SEC, Kalif has control over a total of 403,288 common shares of the company, with 403,288 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000095017025086697/xslF345X05/ownership.xml

Previous page： GoGold Resources Recasts its Los Ricos South Project as an Underground Mine Ahead of a Definitive Feasibility Study Next page： BriaCell Receives Positive Feedback From FDA Meeting Over Potential Prostate Cancer Drug

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

GoGold Resources Recasts its Los Ricos South Project as an Underground Mine Ahead of a Definitive Feasibility Study

Sep 10, 2024

08:24 AM EDT, 09/10/2024 (MT Newswires) -- GoGold Resources ( GLGDF ) on Tuesday said it rethought plans for an open-pit mine at its Los Ricos South project in Mexico, opting for an underground-only project as it readies a definitive feasibility study for the project. The company said focusing on underground mining for the 2,000-tonne per day project lowers its...

BriaCell Receives Positive Feedback From FDA Meeting Over Potential Prostate Cancer Drug

Sep 10, 2024

08:23 AM EDT, 09/10/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) said it has received positive feedback from its pre-Investigational New Drug meeting with the US Food and Drug Administration for its Bria-PROS+ as a potential treatment of advanced prostate cancer. The meeting was a step toward conducting a phase 1/2 study of the treatment. As a result of...

Sector Update: Consumer

Sep 10, 2024

08:46 AM EDT, 09/10/2024 (MT Newswires) -- Consumer stocks were mixed premarket Tuesday, with The Consumer Staples Select Sector SPDR Fund (XLP) down 0.1% and The Consumer Discretionary Select Sector SPDR Fund (XLY) 0.6% higher. Mission Produce ( AVO ) shares were up over 17% after the company overnight reported higher fiscal Q3 adjusted net income and sales. ...

Camden National to Acquire Northway Financial in $86.6 Million All-Stock Deal

Sep 10, 2024

08:49 AM EDT, 09/10/2024 (MT Newswires) -- Camden National ( CAC ) has agreed to acquire Northway Financial in an all-stock deal valued at $86.6 million, the companies said Tuesday. The transaction, expected to close in Q1, will result in a combined company that will operate as Camden National Bank with 74 branches across New Hampshire and Maine, holding about...